Pay in 4 interest-free payments of $6.03 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Supporting daily stressors
This dual hormone mechanism amplifies the metabolic effects: GIP activation appears to work synergistically with GLP-1 receptor activation, producing far greater reductions in body weight and blood sugar levels than GLP-1 alone
Rainero, I., Govone, F., Gai, A., Vacca, A
Although CV outcomes trials with GLP-1RAs (LEADER and SUSTAIN-6) and SGLT2 inhibitors (EMPA-REG OUTCOME and CANVAS) showed significantly reduced occurrences of the pre-specified primary composite endpoint comprised of CV death, non-fatal myocardial infarction, and non-fatal stroke in T2D patients at high risk of CV events, the treatment effects on the individual components of the primary composite endpoint differed between drug classes, and even between different members of the same class [22, 23]
US$ 24.06
US$ 28.48
US$ 25.69
US$ 24.95
US$ 27.04
